Matt Carter | People | McDermott

Overview


Matt Carter advises private equity sponsors, institutional direct investors and strategic acquirors on a wide range of U.S. and cross-border transactions, including leveraged buyouts, growth equity investments, joint ventures and restructurings. He counsels clients across an array of verticals, including healthcare and life sciences, technology, infrastructure, and consumer products.

Results


  • Represented publicly traded Japanese client KAKEN Pharmaceutical Co., Ltd. in its acquisition of Aadi Bioscience, Inc. and substantially all of its assets, including FYARRO®, a drug for treating malignant perivascular epithelioid cell tumor (PEComa) in adults
  • Represented a US search engine optimization company in its sale, for cash and stock, of substantially all assets, to a Nasdaq Nordic listed online gaming concern
  • Represented the family office of a multiple-time MVP NBA player, in numerous joint ventures, endorsement deals and corporate matters

Show More

Credentials


Education
Stanford University, JD
Claremont Graduate University, MA
Pomona College, BA

Admissions
California
New York